Utilização De Finasterida No Tratamento Da Hiperplasia Prostática Benigna – Relato De Caso

The case report discusses the use of finasteride, a 5a-reductase inhibitor, in treating benign prostatic hyperplasia (BPH) in a 10-year-old German Shepherd. The treatment initially succeeded in reducing prostate size and alleviating symptoms, but the condition regressed after discontinuation of the medication. Continuous use of finasteride is necessary to maintain its benefits, which can lead to dependency and potential side effects. The study highlights the effectiveness of finasteride in managing BPH but also underscores the need for ongoing treatment and the associated financial and physiological implications.